
Biohaven rose 67.1% from $8.27 to $13.82, ahead of the S&P 500's +13.3%. Its worst day was Sep 10 (−14.7%), and its low came Mar 30 at $8.09.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Biohaven shares rose 14.3%, while the S&P 500 fell 0.8%.
+14.3% · S&P 500 −0.8%
Biohaven shares rose 22.0%, while the S&P 500 fell 0.3%.
+22.0% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $-1.21 missed the $-1.06 estimate on $0.00 revenue (est. $1.5M).
−9.7% · S&P 500 −0.9%
Biohaven closed at its lowest level of the year, 2.2% below where the year started.
−3.3% · S&P 500 −0.3%
EPS of $-0.69 beat the $-0.78 estimate on $0.00 revenue (est. $8.3M).
−4.2% · S&P 500 +0.8%
EPS of $-0.78 missed the $-0.64 estimate on $0.00 revenue.
−0.3% · S&P 500 −0.3%
Biohaven closed at its highest level of the year, 105.0% above where the year started.
+17.9% · S&P 500 0.0%
Biohaven shares rose 15.6%, while the S&P 500 rose 0.9%.
+15.6% · S&P 500 +0.9%
Biohaven shares rose 25.0%, while the S&P 500 fell 1.2%.
+25.0%, the year's best day, on 31M shares, the year's heaviest volume · S&P 500 −1.2%
EPS of $-0.73 missed the $-0.03 estimate on $0.00 revenue (est. $110.0M).
−6.5% · S&P 500 −1.8%
Where it ended: a close of $13.82 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 11, 2027 (EPS est. $0.28, revenue est. $131.1M).
Nothing in the past 12 months.
All BHVN dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BHVN and SPY from Benzinga historical bars. Not investment advice.